Non-HFE Hemochromatosis

 

 Buy Article Permissions and Reprints

ABSTRACT

The term “non-HFE hemochromatosis” (non-HFE HC) refers to several phenotypically similar but genetically distinct forms of hereditary hemochromatosis affecting individuals without pathogenic mutations of HFE. The involved genes are, sinsu strictu, transferrin receptor 2 (TfR2), hemojuvelin (HJV), and hepcidin (HAMP). Non-HFE HC share common pathogenic and clinical features with HFE HC. However, depending on the role of the affected gene in iron trafficking, the clinical onset may be earlier and phenotypic expressivity more severe than classic HC. Other forms of hereditary iron overload have distinct pathogenesis and phenotype. The most prevalent of these forms is “ferroportin disease,” characterized by autosomal dominant trait, predominant reticuloendothelial cell iron overload, and mild organ damage. Non-HFE HC gene products, while responsible for rarer cases of HC as compared with HFE, are much more central than HFE in human iron homeostasis and understanding their function will greatly advance our comprehension of iron trafficking in health and disease.

REFERENCES

• 1 Feder J N, Gnirke A, Thomas W et al.. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.  Nat Genet. 1996;  13 399-408
  CrossrefPubMedGoogle Scholar
• 2 Piperno A, Sampietro M, Pietrangelo A et al.. Heterogeneity of hemochromatosis in Italy.  Gastroenterology. 1998;  114 996-1002
  PubMedGoogle Scholar
• 3 Borot N, Roth M, Malfroy L et al.. Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients.  Immunogenetics. 1997;  45 320-324
  CrossrefPubMedGoogle Scholar
• 4 Pietrangelo A. Hemochromatosis 1998: is one gene enough?.  J Hepatol. 1998;  29 502-509
  CrossrefPubMedGoogle Scholar
• 5 Pietrangelo A. Hereditary hemochromatosis-a new look at an old disease.  N Engl J Med. 2004;  350 2383-2397
  CrossrefPubMedGoogle Scholar
• 6 Pietrangelo A. The ferroportin disease.  Blood Cells Mol Dis. 2004;  32 131-138
  CrossrefPubMedGoogle Scholar
• 7 Harris Z L, Takahashi Y, Miyajima H et al.. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.  Proc Natl Acad Sci USA. 1995;  92 2539-2543
  CrossrefPubMedGoogle Scholar
• 8 Hayashi A, Wada Y, Suzuki T, Shimizu A. Studies on familial hypotransferrinemia-unique clinical course and molecular pathology.  Am J Hum Genet. 1993;  53 201-213
  PubMedGoogle Scholar
• 9 Camaschella C, Roetto A, Cali A et al.. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22.  Nat Genet. 2000;  25 14-15
  CrossrefPubMedGoogle Scholar
• 10 Kawabata H, Yang R, Hirama T et al.. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family.  J Biol Chem. 1999;  274 20826-20832
  CrossrefPubMedGoogle Scholar
• 11 Roetto A, Totaro A, Piperno A et al.. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3.  Blood. 2001;  97 2555-2560
  CrossrefPubMedGoogle Scholar
• 12 Mattman A, Huntsman D, Lockitch G et al.. Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutation.  Blood. 2002;  100 1075-1077
  CrossrefPubMedGoogle Scholar
• 13 Hattori A, Wakusawa S, Hayashi H et al.. AVAQ 594-597 deletion of the TfR2 gene in a Japanese family with hemochromatosis.  Hepatol Res. 2003;  26 154-156
  CrossrefPubMedGoogle Scholar
• 14 Le Gac G, Mons F, Jacolot S, Scotet V, Ferec C, Frebourg T. Early onset hereditary hemochromatosis resulting from a novel TFR2 gene nonsense mutation (R105X) in two siblings of north French descent.  Br J Haematol. 2004;  125 674-678
  CrossrefPubMedGoogle Scholar
• 15 Kawabata H, Nakamaki T, Ikonomi P et al.. Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells.  Blood. 2001;  98 2714-2719
  CrossrefPubMedGoogle Scholar
• 16 Cairo G, Pietrangelo A. Iron regulatory proteins in pathobiology.  Biochem J. 2000;  352(Pt 2) 241-250
  CrossrefPubMedGoogle Scholar
• 17 Kawabata H, Germain R S, Vuong P T et al.. Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo.  J Biol Chem. 2000;  275 16618-16625
  CrossrefPubMedGoogle Scholar
• 18 Trinder D, Baker E. Transferrin receptor 2: a new molecule in iron metabolism.  Int J Biochem Cell Biol. 2003;  35 292-296
  CrossrefPubMedGoogle Scholar
• 19 West Jr A P, Bennett M J, Sellers V M, Andrews N C, Enns C A, Bjorkman P J. Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE.  J Biol Chem. 2000;  275 38135-38138
  CrossrefPubMedGoogle Scholar
• 20 Richardson D R, Baker E. Two saturable mechanisms of iron uptake from transferrin in human melanoma cells: the effect of transferrin concentration, chelators, and metabolic probes on transferrin and iron uptake.  J Cell Physiol. 1994;  161 160-168
  CrossrefPubMedGoogle Scholar
• 21 Lamon J M, Marynick S P, Roseblatt R, Donnelly S. Idiopathic hemochromatosis in a young female. A case study and review of the syndrome in young people.  Gastroenterology. 1979;  76 178-183
  PubMedGoogle Scholar
• 22 Roetto A, Papanikolaou G, Politou M et al.. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis.  Nat Genet. 2003;  33 21-22
  CrossrefPubMedGoogle Scholar
• 23 Krause A, Neitz S, Magert H J et al.. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity.  FEBS Lett. 2000;  480 147-150
  CrossrefPubMedGoogle Scholar
• 24 Park C H, Valore E V, Waring A J, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver.  J Biol Chem. 2001;  276 7806-7810
  CrossrefPubMedGoogle Scholar
• 25 Pigeon C, Ilyin G, Courselaud B et al.. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload.  J Biol Chem. 2001;  276 7811-7819
  CrossrefPubMedGoogle Scholar
• 26 Nemeth E, Tuttle M S, Powelson J et al.. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.  Science. 2004;  306 2090-2093
  CrossrefPubMedGoogle Scholar
• 27 Nicolas G, Bennoun M, Devaux I et al.. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice.  Proc Natl Acad Sci USA. 2001;  98 8780-8785
  CrossrefPubMedGoogle Scholar
• 28 Courselaud B, Pigeon C, Inoue Y et al.. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism.  J Biol Chem. 2002;  277 41163-41170
  CrossrefPubMedGoogle Scholar
• 29 Roetto A, Totaro A, Cazzola M et al.. Juvenile hemochromatosis locus maps to chromosome 1q.  Am J Hum Genet. 1999;  64 1388-1393
  CrossrefPubMedGoogle Scholar
• 30 Papanikolaou G, Samuels M E, Ludwig E H et al.. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis.  Nat Genet. 2004;  36 77-82
  CrossrefPubMedGoogle Scholar
• 31 Lanzara C, Roetto A, Daraio F et al.. The spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis.  Blood. 2004;  103 4317-4321
  CrossrefPubMedGoogle Scholar
• 32 Lee P L, Beutler E, Rao S V, Barton J C. Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin.  Blood. 2004;  103 4669-4671
  CrossrefPubMedGoogle Scholar
• 33 Gehrke S, Pietrangelo A, Kascak M et al.. HJV gene mutations in European patients with juvenile hemochromatosis.  Clin Genet. 2005;  67 425-428
  CrossrefPubMedGoogle Scholar
• 34 Girelli D, Bozzini C, Roetto A et al.. Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene.  Gastroenterology. 2002;  122 1295-1302
  CrossrefPubMedGoogle Scholar
• 35 Cazzola M, Ascari E, Barosi G et al.. Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism.  Hum Genet. 1983;  65 149-154
  CrossrefPubMedGoogle Scholar
• 36 Rivard S R, Mura C, Simard H et al.. Clinical and molecular aspects of juvenile hemochromatosis in Saguenay-Lac-Saint-Jean (Quebec, Canada).  Blood Cells Mol Dis. 2000;  26 10-14
  CrossrefPubMedGoogle Scholar
• 37 De Gobbi M, Roetto A, Piperno A et al.. Natural history of juvenile haemochromatosis.  Br J Haematol. 2002;  117 973-979
  CrossrefPubMedGoogle Scholar
• 38 Bridle K R, Frazer D M, Wilkins S J et al.. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.  Lancet. 2003;  361 669-673
  CrossrefPubMedGoogle Scholar
• 39 Gehrke S G, Kulaksiz H, Herrmann T et al.. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to serum transferrin saturation and non-transferrin-bound iron.  Blood. 2003;  102 371-376
  CrossrefPubMedGoogle Scholar
• 40 Muckenthaler M, Roy C N, Custodio A O et al.. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis.  Nat Genet. 2003;  34 102-107
  CrossrefPubMedGoogle Scholar
• 41 Nicolas G, Viatte L, Lou D Q et al.. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis.  Nat Genet. 2003;  34 97-101
  CrossrefPubMedGoogle Scholar
• 42 Fleming R E, Ahmann J R, Migas M C et al.. Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis.  Proc Natl Acad Sci USA. 2002;  99 10653-10658
  CrossrefPubMedGoogle Scholar
• 43 Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C. Hepcidin is decreased in TFR2-Hemochromatosis.  Blood. 2005;  105 1083-1806
  PubMedGoogle Scholar
• 44 Kawabata H, Fleming R E, Gui D et al.. Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis.  Blood. 2005;  105 376-381
  CrossrefPubMedGoogle Scholar
• 45 Pietrangelo A, Caleffi A, Henrion J et al.. Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes.  Gastroenterology. 2005;  128 470-479
  CrossrefPubMedGoogle Scholar
• 46 Merryweather-Clarke A T, Cadet E, Bomford A et al.. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.  Hum Mol Genet. 2003;  12 2241-2247
  CrossrefPubMedGoogle Scholar
• 47 Jacolot S, Le Gac G, Scotet V et al.. HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype.  Blood. 2004;  103 2835-2840
  CrossrefPubMedGoogle Scholar
• 48 Hofmann W K, Tong X J, Ajioka R S et al.. Mutation analysis of transferrin-receptor 2 in patients with atypical hemochromatosis.  Blood. 2002;  100 1099-1100
  CrossrefPubMedGoogle Scholar
• 49 Pietrangelo A, Montosi G, Totaro A et al.. Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene.  N Engl J Med. 1999;  341 725-732
  CrossrefPubMedGoogle Scholar
• 50 Montosi G, Donovan A, Totaro A et al.. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene.  J Clin Invest. 2001;  108 619-623
  CrossrefPubMedGoogle Scholar
• 51 Njajou O T, Vaessen N, Joosse M et al.. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis.  Nat Genet. 2001;  28 213-214
  CrossrefPubMedGoogle Scholar
• 52 Devalia V, Carter K, Walker A P et al.. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3).  Blood. 2002;  100 695-697
  CrossrefPubMedGoogle Scholar
• 53 Wallace D F, Pedersen P, Dixon J L et al.. Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis.  Blood. 2002;  100 692-694
  CrossrefPubMedGoogle Scholar
• 54 Roetto A, Merryweather-Clarke A T, Daraio F et al.. A valine deletion of ferroportin 1: a common mutation in hemochromastosis type 4.  Blood. 2002;  100 733-734
  CrossrefPubMedGoogle Scholar
• 55 Cazzola M, Cremonesi L, Papaioannou M et al.. Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3).  Br J Haematol. 2002;  119 539-546
  CrossrefPubMedGoogle Scholar
• 56 Hetet G, Devaux I, Soufir N, Grandchamp B, Beaumont C. Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and three new ferroportin (slc11A3) mutations.  Blood. 2003;  102 1904-1910
  CrossrefPubMedGoogle Scholar
• 57 Rivard S R, Lanzara C, Grimard D et al.. Autosomal dominant reticuloendothelial iron overload (HFE type 4) due to a new missense mutation in the FERROPORTIN 1 gene (SLC11A3) in a large French-Canadian family.  Haematologica. 2003;  88 824-826
  PubMedGoogle Scholar
• 58 Jouanolle A M, Douabin-Gicquel V, Halimi C et al.. Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload.  J Hepatol. 2003;  39 286-289
  CrossrefPubMedGoogle Scholar
• 59 Sham R L, Phatak P D, West C et al.. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features.  Blood Cells Mol Dis. 2005;  34 157-161
  CrossrefPubMedGoogle Scholar
• 60 Liu W, Shimomura S, Imanishi H et al.. Hemochromatosis with mutation of the ferroportin 1 (IREG1) gene.  Intern Med. 2005;  44 285-289
  CrossrefPubMedGoogle Scholar
• 61 Wallace D F, Clark R M, Harley H A, Subramaniam V N. Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis.  J Hepatol. 2004;  40 710-713
  CrossrefPubMedGoogle Scholar
• 62 Donovan A, Brownlie A, Zhou Y et al.. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter.  Nature. 2000;  403 776-781
  CrossrefPubMedGoogle Scholar
• 63 McKie A T, Marciani P, Rolfs A et al.. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation.  Mol Cell. 2000;  5 299-309
  CrossrefPubMedGoogle Scholar
• 64 Abboud S, Haile D J. A novel mammalian iron-regulated protein involved in intracellular iron metabolism.  J Biol Chem. 2000;  275 19906-19912
  CrossrefPubMedGoogle Scholar
• 65 Zoller H, Koch R O, Theurl I et al.. Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload.  Gastroenterology. 2001;  120 1412-1419
  PubMedGoogle Scholar
• 66 Zoller H, Pietrangelo A, Vogel W, Weiss G. Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis.  Lancet. 1999;  353 2120-2123
  CrossrefPubMedGoogle Scholar
• 67 Yang F, Liu X B, Quinones M et al.. Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation.  J Biol Chem. 2002;  277 39786-39791
  CrossrefPubMedGoogle Scholar
• 68 Yamaji S, Tennant J, Tandy S et al.. Zinc regulates the function and expression of the iron transporters DMT1 and IREG1 in human intestinal Caco-2 cells.  FEBS Lett. 2001;  507 137-141
  CrossrefPubMedGoogle Scholar
• 69 Yang F, Wang X, Haile D J et al.. Iron increases expression of iron-export protein MTP1 in lung cells.  Am J Physiol Lung Cell Mol Physiol. 2002;  283 L932-L939
  PubMedGoogle Scholar
• 70 Martini L A, Tchack L, Wood R J. Iron treatment downregulates DMT1 and IREG1 mRNA expression in Caco-2 cells.  J Nutr. 2002;  132 693-696
  PubMedGoogle Scholar
• 71 Lymboussaki A, Pignatti E, Montosi G et al.. The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression.  J Hepatol. 2003;  39 710-715
  CrossrefPubMedGoogle Scholar
• 72 Frazer D M, Wilkins S J, Becker E M et al.. Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats.  Gastroenterology. 2002;  123 835-844
  CrossrefPubMedGoogle Scholar
• 73 Schimanski L M, Drakesmith H, Merryweather-Clarke A T et al.. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations.  Blood. 2005;  105 4096-4102
  CrossrefPubMedGoogle Scholar
• 74 Drakesmith H, Schimanski L M, Ormerod E et al.. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin.  Blood. 2005;  106 1092-1097
  CrossrefPubMedGoogle Scholar
• 75 Gualdi R, Casalgrandi G, Montosi G et al.. Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis.  Gastroenterology. 1994;  107 1118-1124
  PubMedGoogle Scholar
• 76 Jouanolle A M, Douabin-Gicquel V, Halimi C et al.. Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload.  J Hepatol. 2003;  39 286-289
  CrossrefPubMedGoogle Scholar
• 77 Beaumont C, Leneuve P, Devaux I et al.. Mutation in the iron responsive element of the L ferritin mRNA in a family with dominant hyperferritinaemia and cataract.  Nat Genet. 1995;  11 444-446
  CrossrefPubMedGoogle Scholar
• 78 Girelli D, Corrocher R, Bisceglia L et al.. Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: a mutation in the iron-responsive element of ferritin L-subunit gene (the “Verona mutation”).  Blood. 1995;  86 4050-4053
  PubMedGoogle Scholar
• 79 Yoshida K, Furihata K, Takeda S et al.. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans.  Nat Genet. 1995;  9 267-272
  CrossrefPubMedGoogle Scholar
• 80 Moirand R, Mortaji A M, Loreal O et al.. A new syndrome of liver iron overload with normal transferrin saturation.  Lancet. 1997;  349 95-97
  CrossrefPubMedGoogle Scholar
• 81 Bothwell T H, Abrahams C, Bradlow B A, Charlton R W. Idiopathic and Bantu hemochromatosis.  Arch Pathol. 1965;  79 163-168
  PubMedGoogle Scholar
• 82 Gordeuk V, Mukiibi J, Hasstedt S J et al.. Iron overload in Africa. Interaction between a gene and dietary iron content.  N Engl J Med. 1992;  326 95-100
  CrossrefPubMedGoogle Scholar
• 83 Moyo V M, Mandishona E, Hasstedt S J et al.. Evidence of genetic transmission in African iron overload.  Blood. 1998;  91 1076-1082
  PubMedGoogle Scholar
• 84 Gordeuk V R, Caleffi A, Corradini E et al.. Iron overload in Africans and African-Americans and a common mutation in the scl40a1 (ferroportin 1) gene.  Blood Cells Mol Dis. 2003;  31 299-304
  CrossrefPubMedGoogle Scholar
• 85 Beutler E, Barton J C, Felitti V J et al.. Ferroportin (SLC11A3) variant associated with iron overload in African-Americans.  Blood Cells Mol Dis. 2003;  31 305-309
  CrossrefPubMedGoogle Scholar
• 86 Eason R J, Adams P C, Aston C E, Searle J. Familial iron overload with possible autosomal dominant inheritance.  Aust N Z J Med. 1990;  20 226-230
  PubMedGoogle Scholar
• 87 Arden K E, Wallace D F, Dixon J L et al.. A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient.  Gut. 2003;  52 1215-1217
  CrossrefPubMedGoogle Scholar
• 88 Goode C A, Dinh C T, Linder M C. Mechanism of copper transport and delivery in mammals: review and recent findings.  Adv Exp Med Biol. 1989;  258 131-144
  PubMedGoogle Scholar
• 89 Miyajima H, Takahashi Y, Kamata T et al.. Use of desferrioxamine in the treatment of aceruloplasminemia.  Ann Neurol. 1997;  41 404-407
  CrossrefPubMedGoogle Scholar
• 90 Kato J, Fujikawa K, Kanda M et al.. A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload.  Am J Hum Genet. 2001;  69 191-197
  CrossrefPubMedGoogle Scholar
• 91 Cox T M, Halsall D J. Hemochromatosis-neonatal and young subjects.  Blood Cells Mol Dis. 2002;  29 411-417
  CrossrefPubMedGoogle Scholar
• 92 OMIM .Online Mendelian Inheritance in Man. Available at: http://www.ncbi.nlm.nih.gov/omim October 13, 2005
  Google Scholar

Antonello PietrangeloM.D. Ph.D. 

Center for Hemochromatosis and Hereditary Liver Diseases, Department of Internal Medicine

University of Modena and Reggio Emilia, Policlinico

Via del Pozzo 71, 41100 Modena, Italy

Email: pietrangelo.antonello@unimore.it